NCT02858310 2026-03-09E7 TCR T Cells for Human Papillomavirus-Associated CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed224 enrolled 15 charts
NCT03610581 2025-02-04Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the CervixJanssen Vaccines & Prevention B.V.Phase 1/2 Terminated9 enrolled 13 charts